Navigation Links
Cord Blood America Enters Agreement With BancoVida, a Cord Blood Collection Company in San Juan, Puerto Rico

LAS VEGAS, Aug. 29, 2011 /PRNewswire/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) announced today it has entered into an agreement with BancoVida ( to offer umbilical cord blood collection services in Puerto Rico and throughout the Caribbean.

The partnership will allow BancoVida and Cord Blood America to educate prospective parents in Puerto Rico and the Caribbean on the value of storing their baby's umbilical cord blood.  The stem cells will be stored at Cord Blood America's state-of-the-art facility in Las Vegas.

"We are very excited about our partnership with BancoVida and for the opportunity to assist them in bringing this potentially life-saving service to an underserved area," said Gabby Stinson, Cord Blood America Project Manager.

Cord blood stem cells, which are collected at birth in a non-invasive procedure, are currently used to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies.  Various studies and clinical trials are currently underway to determine the effectiveness of stem cells in treating some of the most serious diseases, such as diabetes, heart disease, Parkinson's and cerebral palsy for which there is no known cure.

About BancoVida

BancoVida Corp. has been established to develop and market private cord blood banking services to patients in Puerto Rico and the Caribbean.  Our mission is to successfully introduce and become the leader of private cord blood banking in the Caribbean.  BancoVida is the exclusive reseller of cord blood banking services for Cord Blood America and CorCell in Puerto Rico and the Caribbean.  To find out more about BancoVida, visit our website at  

About Cord Blood America

Cord Blood America (OTC Bulletin Board:  CBAI.ob) is the parent company of CorCell Companies, Inc., which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI.ob), visit our website at For investor information, visit

Paul Knopick
E & E Communications

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Report First Quarter Fiscal 2012 Financial Results
2. Cord Blood America Enters Agreement With Premera Blue Cross to Offer Member Discount on Stem Cell Collection Services
3. Cord Blood America Six Month Revenues Up 61 Percent; Gross Profit Up 100 Percent
4. Restoring blood flow
5. Parents Guide to Cord Blood Foundation Launches Nations First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood
6. Making blood-sucking deadly for mosquitoes
7. Cord Blood America CEO Matthew Schissler Interviewed on International Successes
8. "Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use
9. CorCell, a Cord Blood America Company, Launches Referral Rewards Program
10. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
11. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 the United ... Europe .  PRCC represents about 14% of all new cases ... , Canada and Europe ... kidney cancer.   --> Hutchison China MediTech Limited ("Chi-Med") ... R&D subsidiary, and AstraZeneca AB (publ) ("AstraZeneca") have completed enrolment in ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. ... (FDA) has designated its lead Microbiota Restoration Therapy ... treatment of recurrent Clostridium difficile (C ... infection that causes 29,000 deaths in the U.S. ... biotechnology company that was founded to revolutionize the ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... CA (PRWEB) , ... October 12, 2015 , ... ... announced the launch of LifeTrak Zoom, the world’s first amphibious fitness tracker that seeks ... that offers flexwear technology and accurate heart rate monitoring both in water ...
Breaking Biology Technology:
(Date:9/30/2015)... -- The global glucose monitoring device and diabetes management market is ... report on the industry from Kalorama Information. Sales in the traditional ... by continuous glucose monitoring and sensor segment, according to the ... products in its latest report, The Global Glucose Monitoring ... , ...
(Date:9/28/2015)... -- The global image sensors market ... by 2020, growing at a CAGR of 4.6% from ... (BSI) technique to improve picture quality are expected to ...      (Logo: , The light falls ... and, thus, reduce the noise interference and increase picture ...
(Date:9/24/2015)... LONDON , September 24, 2015 /PRNewswire/ ... 00.01 25 september 2015 Kerv ... inom digitala finanstjänster, lanserar idag världens första ... att samla in 77 000 GBP för ... ) , ...
Breaking Biology News(10 mins):